JR-141, Elaprase 2 mg/ml concentrate for solution for infusion
JR-141-GS31
Phase 3 small_molecule active
Quick answer
JR-141, Elaprase 2 mg/ml concentrate for solution for infusion for Mucopolysaccharidosis type II, Hunter Syndrome is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Mucopolysaccharidosis type II, Hunter Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active